Amy A. Case

783 total citations
44 papers, 256 citations indexed

About

Amy A. Case is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amy A. Case has authored 44 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 15 papers in Pharmacology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amy A. Case's work include Cannabis and Cannabinoid Research (14 papers), Palliative Care and End-of-Life Issues (11 papers) and Pain Management and Opioid Use (7 papers). Amy A. Case is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Palliative Care and End-of-Life Issues (11 papers) and Pain Management and Opioid Use (7 papers). Amy A. Case collaborates with scholars based in United States, Australia and Japan. Amy A. Case's co-authors include Eric Hansen, David E. Weissman, Mellar P. Davis, Gregory B. Crawford, Kimberson Tanco, Carole Bouleuc, David Hui, Deborah P. Waldrop, Andrea Sbrana and Sandip Mukhopadhyay and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Pain and Symptom Management.

In The Last Decade

Amy A. Case

37 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy A. Case United States 10 126 69 59 46 32 44 256
Lauren Meador United States 9 89 0.7× 58 0.8× 42 0.7× 26 0.6× 67 2.1× 13 253
Ebtesam Ahmed United States 9 158 1.3× 120 1.7× 45 0.8× 18 0.4× 136 4.3× 24 366
Maureen Lynch United States 8 98 0.8× 69 1.0× 18 0.3× 46 1.0× 48 1.5× 13 204
Jennifer Mongoven United States 9 76 0.6× 29 0.4× 44 0.7× 118 2.6× 19 0.6× 15 288
Cordt T. Kassner United States 10 208 1.7× 93 1.3× 19 0.3× 93 2.0× 47 1.5× 21 311
Rouzi Shengelia United States 8 106 0.8× 42 0.6× 61 1.0× 89 1.9× 20 0.6× 12 296
Katie Fitzgerald Jones United States 9 169 1.3× 66 1.0× 20 0.3× 27 0.6× 109 3.4× 40 249
Eileen Mann United Kingdom 6 175 1.4× 65 0.9× 90 1.5× 121 2.6× 44 1.4× 14 312
Nicolas Dugré Canada 9 74 0.6× 18 0.3× 58 1.0× 34 0.7× 28 0.9× 25 255
Eric Dawson United States 8 254 2.0× 86 1.2× 38 0.6× 26 0.6× 35 1.1× 14 370

Countries citing papers authored by Amy A. Case

Since Specialization
Citations

This map shows the geographic impact of Amy A. Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Case more than expected).

Fields of papers citing papers by Amy A. Case

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy A. Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Case. The network helps show where Amy A. Case may publish in the future.

Co-authorship network of co-authors of Amy A. Case

This figure shows the co-authorship network connecting the top 25 collaborators of Amy A. Case. A scholar is included among the top collaborators of Amy A. Case based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy A. Case. Amy A. Case is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Davis, Mellar P., Andrew Davies, Mary Lynn McPherson, et al.. (2025). Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline. Supportive Care in Cancer. 33(3). 243–243.
3.
Schlienz, Nicolas J., Amy A. Case, Cheryl Rivard, et al.. (2024). Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors. Supportive Care in Cancer. 32(4). 210–210.
4.
5.
Davis, Mellar P., Andrew Davies, Mary Lynn McPherson, et al.. (2024). Correction to: Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline. Supportive Care in Cancer. 32(9). 596–596. 1 indexed citations
6.
Loggers, Elizabeth T., Amy A. Case, Marcin Chwistek, et al.. (2023). ADCC's Improving Goal Concordant Care Initiative: Implementing Primary Palliative Care Principles. Journal of Pain and Symptom Management. 66(2). e283–e297. 4 indexed citations
7.
Hansen, Eric, et al.. (2023). Medical Cannabis for Insomnia in a Patient With Advanced Breast Cancer. Journal of Pain and Symptom Management. 65(5). e497–e502. 2 indexed citations
8.
Feo, Giulia De, Amy A. Case, Gregory B. Crawford, et al.. (2023). Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. Supportive Care in Cancer. 31(3). 176–176. 13 indexed citations
9.
Walter, Michelle, et al.. (2023). Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center. Journal of Pain and Symptom Management. 67(1). 20–26. 1 indexed citations
10.
Davis, Mellar P., Andrea Sbrana, David Hui, et al.. (2023). MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events. Supportive Care in Cancer. 31(4). 202–202. 21 indexed citations
11.
12.
Hui, David, Sandip Mukhopadhyay, Carole Bouleuc, et al.. (2022). Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Supportive Care in Cancer. 31(1). 39–39. 17 indexed citations
13.
Case, Amy A., et al.. (2022). Pembrolizumab toxicity in non-small cell lung cancer: a retrospective analysis. Lung Cancer. 165. S37–S38.
14.
Hansen, Eric, et al.. (2020). How Effective Is Palliative Care in Improving Patient Outcomes?. Current Treatment Options in Oncology. 21(2). 12–12. 20 indexed citations
15.
Hansen, Eric, Mary M. Mitchell, Michelle Walter, et al.. (2019). Chronic Pain, Functional Status, and Life Satisfaction Are Associated With Patients Living With HIV Discussing Advance Care Planning With Their Family or Friends. Journal of Pain and Symptom Management. 57(5). 961–965. 4 indexed citations
16.
17.
Wang, Chong, et al.. (2018). A Retrospective Review of the Management of Malignant Bowel Obstruction at a Large, Tertiary Cancer Care Center (FR481A). Journal of Pain and Symptom Management. 55(2). 631–632. 1 indexed citations
18.
Hansen, Eric, Xiao Wang, Amy A. Case, Igor Puzanov, & Thomas J. Smith. (2018). Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care Clinician. Journal of Pain and Symptom Management. 56(3). 460–472. 11 indexed citations
19.
Meeker, Mary Ann, et al.. (2013). Contending With Advanced Illness: Patient and Caregiver Perspectives. Journal of Pain and Symptom Management. 47(5). 887–895. 17 indexed citations
20.
Case, Amy A., et al.. (2013). Palliative Medicine Physician Education in the United States: A Historical Review. Journal of Palliative Medicine. 16(3). 230–236. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lauren Meador Breakdown of academic impact, for papers by Ebtesam Ahmed Breakdown of academic impact, for papers by Maureen Lynch Breakdown of academic impact, for papers by Jennifer Mongoven Breakdown of academic impact, for papers by Cordt T. Kassner Breakdown of academic impact, for papers by Rouzi Shengelia Breakdown of academic impact, for papers by Katie Fitzgerald Jones Breakdown of academic impact, for papers by Eileen Mann Breakdown of academic impact, for papers by Nicolas Dugré Breakdown of academic impact, for papers by Eric Dawson
Rankless by CCL
2026